computing basic
earnings per
share 32,272,938 32,143,695 32,230,671 32,099,641
Shares used in
computing diluted
earnings per
share 32,519,324 32,473,578 32,463,488 32,471,120
Condensed Consolidated Balance Sheets Data
July 31, October 31,
2007 2006
Assets:
Cash, cash equivalents and short-term
investments $17,875 $26,828
Accounts receivable, net 37,308 32,746
Inventories, net 111,049 112,320
Other current assets 6,888 10,074
Property, plant and equipment, net 280,592 286,922
Long-term deferred tax asset 34,536 41,619
Goodwill and other, net 85,037 87,464
Total assets $573,285 $597,973
Liabilities and stockholders' equity:
Current liabilities $26,633 $49,786
Non-current liabilities 36,184 55,612
Stockholders' equity 510,468 492,575
Total liabilities and stockholders' equity $573,285 $597,973
Condensed Consolidated Cash Flow Data
Nine months ended July 31,
2007 2006
Operating activities:
Net income $13,745 $14,836
Non-cash items 29,202 27,301
Changes in operating assets and liabilities,
net
'/>"/>
| SOURCE Martek Biosciences Corporation Copyright©2007 PR Newswire. All rights reserved |